Sars - seryl-aminoacyl-tRNA synthetase Gene
Also Known as Strs; Sars1; serRS
Species: Mus musculus
Summary
Predicted to enable several functions, including nucleic acid binding activity; protein homodimerization activity; and serine-tRNA Ligase activity. Predicted to be involved in negative regulation of angiogenesis; negative regulation of macromolecule metabolic process; and seryl-tRNA aminoacylation. Predicted to act upstream of or within translation. Located in mitochondrion. Is expressed in several structures, including alimentary system; cardiovascular system; central nervous system; egg cylinder; and genitourinary system. Human ortholog(s) of this gene implicated in intellectual disability. Orthologous to human SARS1 (seryl-tRNA synthetase 1). [provided by Alliance of Genome Resources, Apr 2022]
Sars Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001204979.1 | NP_001191908.1 | serine--tRNA ligase, cytoplasmic isoform 2 |
| NM_011319.3 | NP_035449.1 | serine--tRNA ligase, cytoplasmic isoform 1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
serine--tRNA ligase, cytoplasmic |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-17589A | Chloroquine | Inhibitor | 99.50% | Yes |
| HY-15463 | Imatinib | 99.95% | Yes | |
| HY-W031727 | Hydroxychloroquine | Inhibitor | 99.82% | Yes |
| HY-17589 | Chloroquine phosphate | Inhibitor | 99.89% | Yes |
| HY-B1123 | Auranofin | Inhibitor | 99.71% | Yes |
| HY-13771 | Ursodeoxycholic acid | 99.94% | Unkown | |
| HY-15310 | Ivermectin | 98.28% | Unkown | |
| HY-B0879A | Suramin sodium salt | 99.98% | Yes | |
| HY-104077 | Remdesivir | Inhibitor | 99.95% | Yes |
| HY-13324 | Bardoxolone methyl | 99.66% | Yes | |
| HY-90001 | Ritonavir | 99.96% | Yes | |
| HY-B1370 | Hydroxychloroquine sulfate | Inhibitor | 99.99% | Yes |
| HY-138687 | Nirmatrelvir | Inhibitor | 99.74% | Unkown |
| HY-135853 | Molnupiravir | Inhibitor | 99.94% | Unkown |
| HY-13765 | 6-Thioguanine | 99.54% | Yes | |
| HY-14434 | Asunaprevir | Inhibitor | 99.84% | Unkown |
| HY-14588 | Lopinavir | Inhibitor | 99.71% | Yes |
| HY-N6972 | Cepharanthine | 99.87% | Yes | |
| HY-N7073 | Silymarin | Inhibitor | 84.0% | Unkown |
| HY-15298 | Grazoprevir | Inhibitor | 99.90% | Unkown |
| HY-109192 | Tolebrutinib | Inhibitor | 99.12% | Yes |
| HY-13512 | Camostat mesylate | Inhibitor | 99.94% | Unkown |
| HY-10241 | Simeprevir | Inhibitor | 98.79% | Unkown |
| HY-107931 | Propiolactone | Inhibitor | 99.36% | Unkown |
| HY-B0539 | Desloratadine | 99.98% | Yes | |
| HY-B1028 | Pantethine | Inhibitor | 99.91% | Yes |
| HY-19344 | Lifitegrast | Antagonist | 99.29% | Unkown |
| HY-17634 | Glecaprevir | Inhibitor | 99.93% | Unkown |
| HY-15602 | Ledipasvir | Inhibitor | 99.69% | Yes |
| HY-12530 | Velpatasvir | Inhibitor | 99.83% | Unkown |
| HY-16050 | Plitidepsin | Inhibitor | 99.94% | Unkown |
| HY-17470 | Mizoribine | Inhibitor | 99.99% | Yes |
| HY-17042 | Cetirizine | Antagonist | 99.79% | Yes |
| HY-12594 | Paritaprevir | Inhibitor | 99.84% | Unkown |
| HY-P0012 | Aviptadil | Inhibitor | 99.95% | Unkown |
| HY-10235 | Telaprevir | Inhibitor | 99.77% | Unkown |
| HY-17367 | Atazanavir | 99.23% | Yes | |
| HY-A0081 | Fluphenazine dihydrochloride | Inhibitor | 99.91% | Unkown |
| HY-15298A | Grazoprevir potassium salt | Inhibitor | 99.79% | Unkown |
| HY-B0182 | Carmofur | Inhibitor | 99.95% | Unkown |
| HY-17437A | Mefloquine hydrochloride | 99.98% | Yes | |
| HY-A0097 | Teicoplanin | Inhibitor | 86.70% | Unkown |
| HY-B0689A | Indinavir sulfate | 99.97% | Yes | |
| HY-B0157 | Ketotifen | Inhibitor | 99.94% | Yes |
| HY-17042A | Cetirizine dihydrochloride | Antagonist | 99.58% | Yes |
| HY-15148 | Tipranavir | Inhibitor | 98.0% | Yes |
| HY-17589B | Chloroquine dihydrochloride | Inhibitor | 99.61% | Yes |
| HY-10238 | Danoprevir | Inhibitor | 99.67% | Unkown |
| HY-B0157A | Ketotifen fumarate | Inhibitor | 99.88% | Yes |
| HY-B0462 | Azelastine hydrochloride | 99.93% | Unkown | |
| HY-17437 | Mefloquine | 99.79% | Yes | |
| HY-19344A | Lifitegrast sodium | Inhibitor | 99.20% | Unkown |
| HY-B0961 | Merbromin | Inhibitor | / | Unkown |
| HY-14904A | Umifenovir hydrochloride | Inhibitor | 99.86% | Unkown |
| HY-Y0189 | Methyl Salicylate | Inhibitor | 99.98% | Unkown |
| HY-19627A | Naldemedine tosylate | Antagonist | 90.0% | Unkown |
| HY-P0012A | Aviptadil acetate | Inhibitor | 99.87% | Unkown |
| HY-14904 | Umifenovir | Inhibitor | 98.04% | Unkown |
| HY-B1400 | Diiodohydroxyquinoline | Inhibitor | 98.0% | Unkown |
| HY-P0205B | Saralasin TFA | Antagonist | 99.37% | Unkown |
| HY-17367A | Atazanavir sulfate | 99.68% | Yes | |
| HY-10237 | Boceprevir | Inhibitor | 98.52% | Unkown |
| HY-17430 | Amprenavir | Inhibitor | 99.55% | Yes |
| HY-119980 | Fluphenazine | 98.70% | Unkown | |
| HY-10300 | Narlaprevir | Inhibitor | 98.15% | Unkown |
| HY-B0372A | Bromhexine hydrochloride | 99.93% | Unkown | |
| HY-B1624A | Debrisoquin hemisulfate | 99.94% | Unkown | |
| HY-P0205 | Saralasin | Antagonist | 99.46% | Unkown |
| HY-15298B | Grazoprevir hydrate | Inhibitor | 99.99% | Unkown |
| HY-12502A | Efonidipine hydrochloride monoethanolate | Inhibitor | 99.83% | Unkown |
| HY-B0689 | Indinavir | 99.96% | Yes | |
| HY-P1564A | [Sar1, Ile8]-Angiotensin II TFA | 99.85% | Unkown | |
| HY-13765R | 6-Thioguanine (Standard) | 98.41% | Unkown | |
| HY-126937 | Ivermectin B1a | Inhibitor | 99.97% | Unkown |
| HY-12502 | Efonidipine | Inhibitor | 99.88% | Unkown |
| HY-16952 | Bepridil | Inhibitor | 99.93% | Unkown |
| HY-B0462A | Azelastine | 99.92% | Unkown | |
| HY-W039454 | 2,4-Dichlorobenzyl alcohol | Inhibitor | 99.84% | Unkown |
| HY-B0879 | Suramin | / | Unkown | |
| HY-B1607 | Chlorphenoxamine | Inhibitor | 99.20% | Unkown |
| HY-10241A | Simeprevir sodium | Inhibitor | / | Unkown |
| HY-19627 | Naldemedine | Antagonist | / | Unkown |
| HY-90001R | Ritonavir (Standard) | 99.70% | Unkown | |
| HY-B1370A | (S)-Hydroxychloroquine | Inhibitor | / | Unkown |
| HY-B1370B | (R)-Hydroxychloroquine | Inhibitor | / | Unkown |
| HY-12594A | Paritaprevir dihydrate | Inhibitor | / | Unkown |
| HY-119980A | Fluphenazine dimaleate | / | Unkown | |
| HY-119980B | Fluphenazine hydrochloride | / | Unkown | |
| HY-14588R | Lopinavir (Standard) | Inhibitor | / | Unkown |
| HY-15602C | Ledipasvir hydrochloride | Inhibitor | / | Unkown |
| HY-A0081R | Fluphenazine dihydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-B0689B | Indinavir sulfate ethanolate | / | Unkown | |
| HY-B0693A | Ranitidine bismuth citrate | / | Unkown | |
| HY-B1607A | Chlorphenoxamine hydrochloride | Inhibitor | / | Unkown |
| HY-P0205A | Saralasin acetate hydrate | Antagonist | / | Unkown |
| HY-P1564 | [Sar1, Ile8]-Angiotensin II | / | Unkown | |
| HY-W039454R | 2,4-Dichlorobenzyl alcohol (Standard) | Inhibitor | / | Unkown |
| HY-109192R | Tolebrutinib (Standard) | Inhibitor | / | Unkown |
| HY-12502AR | Efonidipine hydrochloride monoethanolate (Standard) | Inhibitor | / | Unkown |
| HY-12502B | Efonidipine hydrochloride | Inhibitor | / | Unkown |
| HY-15298C | Grazoprevir sodium salt | Inhibitor | / | Unkown |
| HY-B1624 | Debrisoquin | Inhibitor | / | Unkown |
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99901 | Sibeprenlimab | Inhibitor | 99.82% | Unkown |
| HY-P99376 | Narsoplimab | Inhibitor | ≥99.0% | Unkown |
| HY-P99340 | Sotrovimab | Inhibitor | 96.80% | Unkown |
| HY-P99556 | Tixagevimab | Inhibitor | 99.05% | Unkown |
| HY-P99341 | Casirivimab | Inhibitor | 99.54% | Unkown |
| HY-P99346 | Regdanvimab | Inhibitor | 95.00% | Unkown |
| HY-P9807 | Anti-SARS-CoV-2 Spike mAb (CR3022) | Inhibitor | 95.00% | Unkown |
| HY-P9801 | Anti-Spike-RBD mAb | / | Unkown | |
| HY-P9803 | Anti-SARS-80R mAb | Inhibitor | 95.00% | Unkown |
| HY-P9802 | Anti-Spike-RBD Single Domain mAb | / | Unkown |
Clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-N0063 | Punicalagin | Inhibitor | 99.90% | Phase 4 |
| HY-W088075 | Acriflavine hydrochloride | Inhibitor | 99.4% | Phase 4 |
| HY-104077A | Remdesivir maleate | Inhibitor | / | Phase 4 |
| HY-A0097A | Teicoplanin sodium | Inhibitor | / | Phase 4 |
| HY-109072 | Riamilovir | Inhibitor | / | Phase 4 |
| HY-14909 | Bardoxolone | 99.50% | Phase 3 | |
| HY-156654 | Ibuzatrelvir | Inhibitor | 99.90% | Phase 3 |
| HY-143216 | Ensitrelvir | Inhibitor | 99.61% | Phase 3 |
| HY-145994 | Obeldesivir | Inhibitor | 99.53% | Phase 3 |
| HY-137958 | Bemnifosbuvir hemisulfate | Inhibitor | 98.97% | Phase 3 |
| HY-156655A | Olgotrelvir sodium | Inhibitor | 95.0% | Phase 3 |
| HY-133017 | Amcenestrant | Degrader | 99.79% | Phase 3 |
| HY-154965 | Simnotrelvir | Inhibitor | 99.94% | Phase 3 |
| HY-153121 | Leritrelvir | Inhibitor | 99.17% | Phase 3 |
| HY-138078 | Lufotrelvir | Inhibitor | 99.87% | Phase 3 |
| HY-145119AS | Mindeudesivir hydrobromide | Inhibitor | 98.16% | Phase 3 |
| HY-133894 | Bofutrelvir | Inhibitor | 95.0% | Phase 3 |
| HY-16762 | Artefenomel | 99.14% | Phase 3 | |
| HY-105086 | Pamaqueside | Inhibitor | / | Phase 3 |
| HY-156655 | Olgotrelvir | Inhibitor | / | Phase 3 |
| HY-100442 | Paquinimod | Inhibitor | 99.90% | Phase 2 |
| HY-108325 | Brequinar | Inhibitor | 99.94% | Phase 2 |
| HY-101563 | GSK3326595 | Inhibitor | 99.83% | Phase 2 |
| HY-112163 | Zotatifin | 99.69% | Phase 2 | |
| HY-137978A | Ezurpimtrostat hydrochloride | 99.26% | Phase 2 | |
| HY-16526 | Pilaralisib | Inhibitor | 99.14% | Phase 2 |
| HY-15687A | SAR407899 | Inhibitor | 99.67% | Phase 2 |
| HY-137958A | Bemnifosbuvir | Inhibitor | 99.00% | Phase 2 |
| HY-148787 | Oditrasertib | Inhibitor | 99.84% | Phase 2 |
| HY-172437 | Secutrelvir | Inhibitor | 99.64% | Phase 2 |
| HY-15687 | SAR407899 hydrochloride | Inhibitor | 99.14% | Phase 2 |
| HY-156651 | Zevotrelvir | Inhibitor | 99.71% | Phase 2 |
| HY-P10018 | Bamadutide | Agonist | 99.94% | Phase 2 |
| HY-153228 | Pomotrelvir | Inhibitor | 96.73% | Phase 2 |
| HY-16446 | SAR125844 | Inhibitor | 98.17% | Phase 2 |
| HY-108044 | ONO-5334 | Inhibitor | 99.83% | Phase 2 |
| HY-145592 | Ruzotolimod | 99.92% | Phase 2 | |
| HY-137978 | Ezurpimtrostat | 99.37% | Phase 2 | |
| HY-19088 | Oberadilol | Ligand | / | Phase 2 |
| HY-115831 | SAR247799 | Agonist | 99.38% | Phase 1 |
| HY-18649A | Galidesivir | Inhibitor | 99.29% | Phase 1 |
| HY-18986 | SAR405838 | 98.84% | Phase 1 | |
| HY-15837 | SAR-260301 | Inhibitor | 99.95% | Phase 1 |
| HY-18649 | Galidesivir hydrochloride | Inhibitor | 99.88% | Phase 1 |
| HY-152851 | Izumerogant | Inhibitor | 99.95% | Phase 1 |
| HY-W160358 | 2,5-Dimethylcyclohexanol | Inhibitor | 99.88% | Phase 1 |
| HY-170894 | SARS-CoV-2 Mpro-IN-37 | Inhibitor | / | Phase 1 |
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99344 | Bamlanivimab | Inhibitor | 99.97% | Phase 4 |
| HY-P99342 | Imdevimab | Inhibitor | 95.00% | Phase 4 |
| HY-P99103 | Bebtelovimab | Inhibitor | 97.41% | Phase 4 |
| HY-P99347 | Etesevimab | Inhibitor | 98.76% | Phase 4 |
| HY-P99625 | Frexalimab | Inhibitor | 99.00% | Phase 3 |
| HY-P990748 | Lunsekimig | Inhibitor | 99.00% | Phase 3 |
| HY-P99542 | Tusamitamab ravtansine | Inhibitor | 99.04% | Phase 3 |
| HY-P990091 | Riliprubart | Inhibitor | 99.90% | Phase 3 |
| HY-P990756 | Pemivibart | 99.12% | Phase 3 | |
| HY-P991501 | Meplazumab | Inhibitor | 99.25% | Phase 3 |
| HY-P99604 | Cilgavimab | Inhibitor | 95.00% | Phase 3 |
| HY-P99012 | Clazakizumab | Inhibitor | ≥99.0% | Phase 3 |
| HY-P99423 | Adintrevimab | Inhibitor | 96.94% | Phase 3 |
| HY-P99435 | Amubarvimab | Inhibitor | 95.00% | Phase 3 |
| HY-P99889 | Romlusevimab | Inhibitor | 95.00% | Phase 3 |
| HY-145644 | Ogalvibart | Inhibitor | 95.02% | Phase 3 |
| HY-P990052 | Simaravibart | Inhibitor | 98.59% | Phase 3 |
| HY-P99535 | Upanovimab | Inhibitor | 95.627% | Phase 3 |
| HY-P99710 | Lomtegovimab | Inhibitor | 99.94% | Phase 3 |
| HY-145641 | Crexavibart | Inhibitor | / | Phase 3 |
| HY-P99054 | Tusamitamab | Inhibitor | 99.81% | Phase 2 |
| HY-P99947 | Rimteravimab | Inhibitor | ≥99% | Phase 2 |
| HY-P990905 | Bexatamig | Inhibitor | 97.06% | Phase 2 |
| HY-P99431 | KY-1044 | 99.51% | Phase 2 | |
| HY-P99883 | Romilkimab | Inhibitor | / | Phase 2 |
| HY-P99467 | Beludavimab | Inhibitor | 95.61% | Phase 2 |
| HY-P99104 | Plutavimab | Inhibitor | 98.619% | Phase 2 |
| HY-P991382 | SAR-439459 | Inhibitor | / | Phase 2 |
| HY-P99925 | Enoticumab | Inhibitor | 99.64% | Phase 1 |
| HY-P99929 | Enuzovimab | ≥99.0% | Phase 1 | |
| HY-P991183 | SAR-442257 | Inhibitor | ≥99.0% | Phase 1 |
| HY-P990705 | Gorivitug | 98.876% | Phase 1 | |
| HY-P991587 | SAR-446523 | Inhibitor | / | Phase 1 |
| HY-145642 | Masavibart | Inhibitor | / | Phase 1 |
| HY-P991654 | SAR228810 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13433 | Thapsigargin | 99.95% | Unkown | |
| HY-18234A | Leupeptin hemisulfate | Inhibitor | 99.39% | Yes |
| HY-14393 | Emodin | Inhibitor | 99.25% | Yes |
| HY-12481 | SAR405 | Inhibitor | 99.74% | Unkown |
| HY-D0837 | Imidazole | Inhibitor | 99.96% | Unkown |
| HY-108477 | TMPyP4 tosylate | Inhibitor | 98.0% | Unkown |
| HY-160412 | Balinatunfib | Inhibitor | 99.94% | Unkown |
| HY-N1913 | Danshensu | 99.90% | Unkown | |
| HY-15458 | SAR131675 | Inhibitor | 99.85% | Unkown |
| HY-W013151 | 1-Pyrenebutyric acid N-hydroxysuccinimide ester | Chemical | 99.93% | Unkown |
| HY-146246 | EIDD-2749 | Inhibitor | 99.86% | Unkown |
| HY-138794 | XL177A | Inhibitor | 99.60% | Unkown |
| HY-100575 | Acriflavine | Inhibitor | 98.0% | Unkown |
| HY-100211 | TAPI-2 | Inhibitor | 97.41% | Unkown |
| HY-110066 | (Z)-Guggulsterone | 99.41% | Unkown | |
| HY-138113 | Pyrrothiogatain | Inhibitor | 98.61% | Unkown |
| HY-N7378 | N-Hydroxypipecolic acid | ≥98.0% | Unkown | |
| HY-117043 | GRL0617 | Inhibitor | 99.62% | Unkown |
| HY-10929 | UNC0224 | Inhibitor | 98.93% | Unkown |
| HY-15699 | SAR7334 | Inhibitor | 96.96% | Unkown |
| HY-155876 | NVP-DFV890 | Antagonist | 99.97% | Unkown |
| HY-119293 | K777 | Inhibitor | 99.14% | Unkown |
| HY-101984 | N6,N6-Dimethyladenosine | 99.66% | Unkown | |
| HY-W010276 | H-Gly-Sar-OH | 99.87% | Unkown | |
| HY-152955 | STING agonist-22 | Agonist | 99.83% | Unkown |
| HY-146248B | TFMU-ADPr diammonium | 98.78% | Unkown | |
| HY-P3042 | Chymostatin | Inhibitor | 99.9% | Unkown |
| HY-N1996 | Chebulagic acid | Inhibitor | 99.85% | Unkown |
| HY-120852 | JG26 | 98.14% | Unkown | |
| HY-117626 | LP-935509 | Inhibitor | 99.74% | Unkown |
| HY-17589R | Chloroquine phosphate (Standard) | Inhibitor | 99.67% | Unkown |
| HY-B1513 | α-Cyclodextrin | Inhibitor | 99.96% | Unkown |
| HY-W011342 | Fmoc-Sar-OH | 99.93% | Unkown | |
| HY-N2183 | Baimaside | Inhibitor | 99.57% | Unkown |
| HY-W012531 | 2-Hydroxycinnamic acid | Inhibitor | 99.86% | Unkown |
| HY-N3415 | Kumatakenin | 99.31% | Unkown | |
| HY-P11146 | SppIP | Inhibitor | 98.99% | Unkown |
| HY-N1951 | Miltirone | 99.54% | Unkown | |
| HY-N2116 | Ginkgolic acid C17:1 | 99.80% | Unkown | |
| HY-117813 | 2-Thiouridine | Inhibitor | 99.92% | Unkown |
| HY-108137 | Z-LVG-CHN2 | Inhibitor | 99.88% | Unkown |
| HY-G0017 | N-Desmethyl imatinib | 98.33% | Unkown | |
| HY-P5522A | TriDAP dihydrochloride | 99.16% | Unkown | |
| HY-113478S | Ursodeoxycholic acid-d4 | 99.52% | Unkown | |
| HY-N2014 | Verbenalin | Inhibitor | 99.93% | Unkown |
| HY-10930 | UNC0321 | Inhibitor | 99.91% | Unkown |
| HY-N3266 | Methyl rosmarinate | 99.89% | Unkown | |
| HY-W016887 | Glycyl-L-proline | Inducer | 99.88% | Unkown |
| HY-N0713 | Diosmetin-7-O-β-D-glucopyranoside | Inhibitor | 99.61% | Unkown |
| HY-108511 | PB28 dihydrochloride | 99.63% | Unkown | |
| HY-126085 | (±)-Alliin | Inhibitor | 98.21% | Unkown |
| HY-152956 | STING agonist-23 | Agonist | 99.33% | Unkown |
| HY-W015230 | Boc-Sar-OH | 98.0% | Unkown | |
| HY-100895 | SAR-20347 | Inhibitor | 97.27% | Unkown |
| HY-143216A | Ensitrelvir fumarate | Inhibitor | 99.94% | Unkown |
| HY-132280 | Tirilazad | Inhibitor | 98.11% | Unkown |
| HY-B1370R | Hydroxychloroquine sulfate (Standard) | Inhibitor | 99.96% | Unkown |
| HY-N0891 | Tubeimoside II | 99.90% | Unkown | |
| HY-W018758 | 1-Phenylpropane-1,2-dione | 99.76% | Unkown | |
| HY-13807 | UNC0646 | Inhibitor | 99.38% | Unkown |
| HY-150737 | MI-1851 | Inhibitor | 95.92% | Unkown |
| HY-18219 | Walrycin B | Inhibitor | 98.11% | Unkown |
| HY-15699A | SAR7334 hydrochloride | Inhibitor | 96.04% | Unkown |
| HY-N2016 | Arteannuin B | 99.89% | Unkown | |
| HY-159700 | AA3-DLin | 99.0% | Unkown | |
| HY-173521 | JNJ-9676 | Inhibitor | 99.74% | Unkown |
| HY-W028142 | Quipazine | 97.0% | Unkown | |
| HY-153879 | C12-TLRa | Ligand | 99.71% | Unkown |
| HY-12473 | Vps34-IN-2 | Inhibitor | 99.73% | Unkown |
| HY-148072 | MM3122 | Inhibitor | 99.20% | Unkown |
| HY-108986 | JFD00244 | Inhibitor | 99.40% | Unkown |
| HY-145973A | 3'OMe-m7GpppAmpG ammonium solution (100 mM) | Inhibitor | 98.24% | Unkown |
| HY-153235 | COVID-19 Spike Protein mRNA-LNP | / | Unkown | |
| HY-N3389 | Licoisoflavone A | 99.53% | Unkown | |
| HY-W195509 | Debrisoquin hydroiodide | Inhibitor | 99.84% | Unkown |
| HY-109037S3 | Mavacamten-d5 | Modulator | 98.01% | Unkown |
| HY-137048 | PF-00835231 | Inhibitor | 99.31% | Unkown |
| HY-100749 | HeE1-2Tyr | Inhibitor | 96.68% | Unkown |
| HY-108494 | CYM50260 | Agonist | 98.94% | Unkown |
| HY-15458A | (S)-SAR131675 | Inhibitor | 99.72% | Unkown |
| HY-N0886 | Aloin B | Inhibitor | 99.87% | Unkown |
| HY-12648A | FASN-IN-4 tosylate | Inhibitor | 98.55% | Unkown |
| HY-135909 | TH1217 | Modulator | 99.20% | Unkown |
| HY-149535 | Iscartrelvir | Inhibitor | 99.91% | Unkown |
| HY-157403 | Jun12682 | Inhibitor | 99.60% | Unkown |
| HY-171160 | WYFA-15 | Inhibitor | 98.77% | Unkown |
| HY-172760 | CIM-834 | Inhibitor | 99.14% | Unkown |
| HY-17542 | PLpro inhibitor | Inhibitor | 99.88% | Unkown |
| HY-P1012 | [Sar9,Met(O2)11]-Substance P | Agonist | 98.65% | Unkown |
| HY-P4685 | (Sar1,Ile4,8)-Angiotensin II | Agonist | 98.23% | Unkown |
| HY-108447 | BC-11 hydrobromide | Inhibitor | 99.22% | Unkown |
| HY-124564 | Methisazone | Inhibitor | 99.37% | Unkown |
| HY-145119S | Mindeudesivir | 98.20% | Unkown | |
| HY-153894 | SRX3177 | 99.33% | Unkown | |
| HY-156597 | Arbemnifosbuvir | Inhibitor | 99.40% | Unkown |
| HY-161619 | RMC-113 | 99.54% | Unkown | |
| HY-N1739 | Tectoquinone | Inhibitor | 98.40% | Unkown |
| HY-W018062 | H-Sar-OtBu.HCl | 98.0% | Unkown | |
| HY-153083 | COVID-19 Spike Protein mRNA(N1-Me-Pseudo UTP) | Inhibitor | 89% | Unkown |
| HY-136303 | GS-704277 | 98.77% | Unkown | |
| HY-137472 | SAR502250 | Inhibitor | 99.29% | Unkown |
| HY-N1913A | Danshensu sodium | 99.9% | Unkown | |
| HY-100195 | SAR-020106 | Inhibitor | 98.04% | Unkown |
| HY-107735 | CYM 9484 | Antagonist | 98.68% | Unkown |
| HY-118922 | IW927 | Inhibitor | 99.23% | Unkown |
| HY-139165A | AT-9010 tetrasodium | Inhibitor | 99.88% | Unkown |
| HY-155813 | MPI60 | Inhibitor | 98.35% | Unkown |
| HY-W013517 | Z-Sar-OH | 99.69% | Unkown | |
| HY-145119 | GS-621763 | Inhibitor | 99.72% | Unkown |
| HY-107577 | Gedunin | Inhibitor | 99.59% | Unkown |
| HY-118653 | SAR629 | 99.93% | Unkown | |
| HY-14393R | Emodin (Standard) | Inhibitor | 98.84% | Unkown |
| HY-152959 | STING agonist-26 | Agonist | 99.56% | Unkown |
| HY-155488 | SHEN26 | 99.25% | Unkown | |
| HY-161177 | PROTAC SARS-CoV-2 3CLPro degrader 2 | Degrader | 98.59% | Unkown |
| HY-161356 | BPR3P0128 | Inhibitor | 98.58% | Unkown |
| HY-19727A | FOY 251 | Inhibitor | 99.31% | Unkown |
| HY-P10031 | SAR441255 | Agonist | 99.84% | Unkown |
| HY-W112938 | TMPyP tetrachloride | Inhibitor | 98.30% | Unkown |
| HY-163943 | UNI418 | Inhibitor | 99.61% | Unkown |
| HY-P10031A | SAR441255 TFA | Agonist | 99.93% | Unkown |
| HY-147020 | Coronastat | Inhibitor | 98.0% | Unkown |
| HY-136149 | Mpro inhibitor N3 | Inhibitor | 99.76% | Unkown |
| HY-138067 | SSAA09E2 | Inhibitor | 98.37% | Unkown |
| HY-103291 | Sar-[D-Phe8]-des-Arg9-Bradykinin | Agonist | 99.96% | Unkown |
| HY-150062 | SARS-CoV-2 nsp3-IN-1 | Inhibitor | ≥98.0% | Unkown |
| HY-162675 | COB-187 | Inhibitor | 95.0% | Unkown |
| HY-168034 | diABZI-4 | 98.33% | Unkown | |
| HY-169092 | PF-07957472 | Inhibitor | 99.13% | Unkown |
| HY-17042S1 | Cetirizine-d8 | Antagonist | 96.46% | Unkown |
| HY-G0017S | N-Desmethyl imatinib-d8 | 99.95% | Unkown | |
| HY-N8599 | Cichoriin | 99.9% | Unkown | |
| HY-P4388 | Z-Arg-Leu-Arg-Gly-Gly-AMC | 99.93% | Unkown | |
| HY-P4388A | Z-Arg-Leu-Arg-Gly-Gly-AMC acetate | 99.76% | Unkown | |
| HY-12481A | SAR405 R enantiomer | Control | 99.94% | Unkown |
| HY-136149A | Mpro inhibitor N3 hemihydrate | Inhibitor | 99.86% | Unkown |
| HY-17589AS | Chloroquine-d5 | Inhibitor | 99.90% | Unkown |
| HY-135853S | Molnupiravir-d7 | Inhibitor | 99.86% | Unkown |
| HY-132808 | Atuzabrutinib | Inhibitor | 98.00% | Unkown |
| HY-101046 | Quipazine dimaleate | 99.96% | Unkown | |
| HY-124304 | Pinokalant | Inhibitor | 99.09% | Unkown |
| HY-136298A | X77 | Inhibitor | 99.95% | Unkown |
| HY-137954 | GRL-0496 | Inhibitor | 99.20% | Unkown |
| HY-137984 | Cnicin | 99.14% | Unkown | |
| HY-139442 | RdRP-IN-2 | Inhibitor | 98.01% | Unkown |
| HY-144770 | SARS-CoV-2-IN-13 | Inhibitor | 98.53% | Unkown |
| HY-149264 | SARS-CoV-2 3CLpro-IN-13 | Inhibitor | 99.0% | Unkown |
| HY-152101 | LY1 | Inhibitor | 98.01% | Unkown |
| HY-P4198 | Fmoc-N(Me)-Sar10 | 98.22% | Unkown | |
| HY-W024485 | SARS-CoV-2-IN-86 | Inhibitor | 99.35% | Unkown |
| HY-113752 | MMV019313 | Inhibitor | 99.54% | Unkown |
| HY-160554 | C12-113 | 98.67% | Unkown | |
| HY-132306 | CCF0058981 | Inhibitor | 98.02% | Unkown |
| HY-139582 | Simpinicline | 99.45% | Unkown | |
| HY-100442S1 | Paquinimod-d5-1 | Inhibitor | 98.19% | Unkown |
| HY-104077S1 | Remdesivir-d4 | Inhibitor | 99.53% | Unkown |
| HY-126419 | Kobophenol A | Inhibitor | 99.90% | Unkown |
| HY-138102 | SSAA09E3 | Inhibitor | 99.42% | Unkown |
| HY-138794A | (Rac)-XL177A | Inhibitor | / | Unkown |
| HY-149408 | MAOA-IN-1 | Inhibitor | 98.24% | Unkown |
| HY-149606 | TKB245 | Inhibitor | 98.98% | Unkown |
| HY-149954 | SARS-CoV-2-IN-39 | Inhibitor | 99.79% | Unkown |
| HY-150784 | XR8-89 | Inhibitor | 97.13% | Unkown |
| HY-151482 | SARS-CoV-2 Mpro-IN-2 | Inhibitor | 98.96% | Unkown |
| HY-153377 | Lipid 14 | 95.0% | Unkown | |
| HY-153533A | GRL-1720 TFA | Inhibitor | 98.94% | Unkown |
| HY-155144 | CDD-1845 | Inhibitor | 99.60% | Unkown |
| HY-158405 | PAV-104 | Inhibitor | 99.83% | Unkown |
| HY-164166 | Fmoc-Sar-Sar-Sar-OH | 98.45% | Unkown | |
| HY-17042S | Cetirizine-d4 | Antagonist | 99.10% | Unkown |
| HY-175029 | ALG-097558 | Inhibitor | 98.18% | Unkown |
| HY-D1270 | Direct Violet 1 | Inhibitor | / | Unkown |
| HY-N1910 | 4'-O-Methylbavachalcone | Inhibitor | 99.64% | Unkown |
| HY-P1738 | [Sar9] Substance P | Agonist | 98.14% | Unkown |
| HY-P2381 | Sar-Arg-Val-Tyr-Val-His-NH2 | Agonist | 96.63% | Unkown |
| HY-P3138 | (Sar1)-Angiotensin II | Agonist | 99.84% | Unkown |
| HY-P3801 | [Glp5,(Me)Phe8,Sar9] Substance P (5-11) | Modulator | 99.61% | Unkown |
| HY-131603B | Lamivudine triphosphate TEA | Inhibitor | 99.89% | Unkown |
| HY-144800 | FWM-1 | Inhibitor | 95.0% | Unkown |
| HY-155280 | SARS-CoV-2-IN-60 | Inhibitor | 99.22% | Unkown |
| HY-157154 | MAT-POS-e194df51-1 | Inhibitor | 98.45% | Unkown |
| HY-N8671 | Withanoside V | Inhibitor | 99.9% | Unkown |
| HY-N8693 | Withanoside IV | 98.47% | Unkown | |
| HY-P5168S | GPSVFPLAPSSK-13C6,15N2 | Inhibitor | 98.62% | Unkown |
| HY-W004812 | BOC-(1R,3S)-3-aminocyclopentane carboxylic acid | Inhibitor | 98.0% | Unkown |
| HY-W018563 | GCLE | Inhibitor | / | Unkown |
| HY-W1116287 | N-Acetyl-Sar24 | 97.02% | Unkown | |
| HY-W196368 | Thymohydroquinone | Inhibitor | 99.91% | Unkown |
| HY-104077S | Remdesivir-d5 | Inhibitor | 99.86% | Unkown |
| HY-164485 | INI-4001 | / | Unkown | |
| HY-12648 | FASN-IN-4 | Inhibitor | 99.21% | Unkown |
| HY-135855 | SARS-CoV-IN-1 | Inhibitor | 99.88% | Unkown |
| HY-135856 | SARS-CoV-IN-2 | Inhibitor | 98.66% | Unkown |
| HY-135858 | SARS-CoV-IN-3 | Inhibitor | 99.36% | Unkown |
| HY-136259 | ML188 | Inhibitor | 99.87% | Unkown |
| HY-13247 | Setrobuvir | Inhibitor | 99.98% | Unkown |
| HY-136298 | (Rac)-X77 | Inhibitor | 99.65% | Unkown |
| HY-139311 | YH-53 | Inhibitor | 98.78% | Unkown |
| HY-W031727S | Hydroxychloroquine-d4-1 sulfate | Inhibitor | ≥98.0% | Unkown |
| HY-119980S | Fluphenazine-d8 | 99.12% | Unkown | |
| HY-125729 | Ivermectin B1b | Inhibitor | 98.66% | Unkown |
| HY-129116 | SSAA09E1 | Inhibitor | 99.54% | Unkown |
| HY-132886 | SARS-CoV-2-IN-6 | Inhibitor | 99.94% | Unkown |
| HY-136284 | XP-59 | Inhibitor | 99.67% | Unkown |
| HY-136597 | Remdesivir O-desphosphate acetonide impurity | Inhibitor | 99.88% | Unkown |
| HY-139165B | AT-9010 triethylamine | Inhibitor | / | Unkown |
| HY-139683 | Antiviral agent 5 | Chemical | 98.93% | Unkown |
| HY-139908 | MERS-CoV-IN-1 | Inhibitor | 99.53% | Unkown |
| HY-141841 | SARS-CoV-2-IN-7 | Inhibitor | 98.84% | Unkown |
| HY-144771 | SARS-CoV-2-IN-14 | Inhibitor | 99.02% | Unkown |
| HY-144772 | SARS-CoV-2-IN-15 | Inhibitor | 99.65% | Unkown |
| HY-146248A | TFMU-ADPr triethylamine | 97.26% | Unkown | |
| HY-146998 | SARS-CoV-2 3CLpro-IN-2 | Inhibitor | 99.71% | Unkown |
| HY-149321 | SARS-CoV-2 nsp14-IN-3 | Inhibitor | ≥95.0% | Unkown |
| HY-150622 | SARS-CoV-2 nsp13-IN-1 | Inhibitor | 99.91% | Unkown |
| HY-153533 | GRL-1720 | Inhibitor | 98.87% | Unkown |
| HY-15463S2 | Imatinib-d3 hydrochloride | 95.19% | Unkown | |
| HY-157778 | MK-7845 | Inhibitor | / | Unkown |
| HY-158763A | MPI8 TFA | Inhibitor | / | Unkown |
| HY-162484 | GZNL-P36 | Inhibitor | 98.97% | Unkown |
| HY-168457 | RNase L ligand 2 | / | Unkown | |
| HY-170524 | TDI-015051 | Inhibitor | / | Unkown |
| HY-17589S1 | Chloroquine-d4 phosphate | Inhibitor | 98.01% | Unkown |
| HY-179630 | MS102 | Inhibitor | / | Unkown |
| HY-19727 | FOY 251 free base | Inhibitor | / | Unkown |
| HY-B0372AS | Bromhexine-d3 hydrochloride | 99.0% | Unkown | |
| HY-B1028S | Pantethine-15N2 | / | Unkown | |
| HY-N10109A | Gallinamide A TFA | Inhibitor | 99.85% | Unkown |
| HY-N10871 | Neocryptomerin | Inhibitor | 99.14% | Unkown |
| HY-N11722 | Panduratin A | 99.9% | Unkown | |
| HY-N11902 | 1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one | Inhibitor | 95.51% | Unkown |
| HY-N12110 | SMU-CX1 | Inhibitor | 99.9% | Unkown |
| HY-N12697A | Polycarpine hydrochloride | Inhibitor | 98.05% | Unkown |
| HY-N2949 | Bonducellpin D | Inhibitor | 98.0% | Unkown |
| HY-N8306 | Isojacareubin | 98.0% | Unkown | |
| HY-N9351 | Cleistanthin B | Inhibitor | 98.19% | Unkown |
| HY-P1012A | [Sar9,Met(O2)11]-Substance P TFA | Agonist | 98.58% | Unkown |
| HY-P11032 | Mp-4D7-pF2 | Inhibitor | 99.39% | Unkown |
| HY-P5407A | HD5 TFA | Inhibitor | 95.30% | Unkown |
| HY-P5642A | Retrocyclin-101 TFA | Inhibitor | 96.69% | Unkown |
| HY-RS12442 | SAR1A Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-Y0189S | Methyl Salicylate-d4 | 99.8% | Unkown | |
| HY-128788A | ddhCTP trisodium solution (100 mM) | Inhibitor | / | Unkown |
| HY-132191 | Pradimicin A | Inhibitor | / | Unkown |
| HY-14830 | SAR 97276 | Inhibitor | 98.05% | Unkown |
| HY-14904AS | Umifenovir-d6 hydrochloride | Inhibitor | 98.0% | Unkown |
| HY-169171 | Cathepsin L-IN-5 | Inhibitor | 96.05% | Unkown |
| HY-B0190S1 | Nafamostat formate salt-13C6 | 98.11% | Unkown | |
| HY-N0063R | Punicalagin (Standard) | Inhibitor | 98.39% | Unkown |
| HY-162177 | SARS-CoV-2-IN-78 | Inhibitor | / | Unkown |
| HY-145115 | Adeninobananin | Control | / | Unkown |
| HY-135860 | SARS-CoV-2-IN-1 | Inhibitor | / | Unkown |
| HY-151113 | ZINC000104379474 | Inhibitor | / | Unkown |
| HY-18234 | Leupeptin | Inhibitor | / | Unkown |
| HY-100546 | GSK-LSD1 | Inhibitor | / | Unkown |
| HY-136606 | SARS-CoV MPro-IN-1 | Inhibitor | / | Unkown |
| HY-150681 | SARS-CoV-2 nsp14-IN-2 | Inhibitor | / | Unkown |
| HY-183746 | Catechin-5-O-gallate | Inhibitor | / | Unkown |
| HY-183885 | MPI3 | Inhibitor | / | Unkown |
| HY-90001S | Ritonavir-d6 | 98.84% | Unkown | |
| HY-P3492 | SARS-CoV-2-IN-34 | Inhibitor | / | Unkown |
| HY-10237S | Boceprevir-d9 | Inhibitor | / | Unkown |
| HY-14393S | Emodin-d4 | Inhibitor | / | Unkown |
| HY-17367S2 | Atazanavir-d9 | / | Unkown | |
| HY-17367S3 | Atazanavir-d5 | / | Unkown | |
| HY-17430S | Amprenavir-d4 | Inhibitor | / | Unkown |
| HY-100211A | (R)-TAPI-2 | Control | / | Unkown |
| HY-100701 | Dutacatib | Inhibitor | / | Unkown |
| HY-10235S | Telaprevir-d4 | Inhibitor | / | Unkown |
| HY-10241S | Simeprevir-13C,d3 | Inhibitor | / | Unkown |
| HY-104077S2 | Remdesivir impurity 9-d4 | Inhibitor | / | Unkown |
| HY-105026 | Cistinexine | / | Unkown | |
| HY-105690 | SAR-115740 | Antagonist | / | Unkown |
| HY-105721 | Aranotin | Inhibitor | / | Unkown |
| HY-106560 | Proglumetacin | Inhibitor | / | Unkown |
| HY-10661 | FL104 | Agonist | / | Unkown |
| HY-106979 | Olcorolimus | Inhibitor | / | Unkown |
| HY-108137A | Z-L(D-Val)G-CHN2 | Inhibitor | 99.35% | Unkown |
| HY-108511A | PB28 | / | Unkown | |
| HY-110265 | SAR216471 hydrochloride | Antagonist | / | Unkown |
| HY-111970 | SAR113945 | Inhibitor | / | Unkown |
| HY-112894 | ZG-10 | Inhibitor | / | Unkown |
| HY-118326 | MRT 68601 | / | Unkown | |
| HY-119293A | K777 tosylate | Inhibitor | / | Unkown |
| HY-120167 | YM-44778 | Antagonist | / | Unkown |
| HY-121068 | Bisoxatin | Inhibitor | / | Unkown |
| HY-121421 | Diniprofylline | Inhibitor | / | Unkown |
| HY-123050 | (Rac)-SAR131675 | Inhibitor | / | Unkown |
| HY-12435 | SAR216471 | Antagonist | / | Unkown |
| HY-124439 | Setomimycin | Inhibitor | / | Unkown |
| HY-12476 | SAR156497 | Inhibitor | / | Unkown |
| HY-12530S3 | Velpatasvir-13C,d3 | / | Unkown | |
| HY-12605 | SAR107375 | Inhibitor | / | Unkown |
| HY-126416 | Methyl tanshinonate | Inhibitor | / | Unkown |
| HY-126937S | Ivermectin B1a-d2-1 | Inhibitor | / | Unkown |
| HY-127083 | Artecanin | Inhibitor | / | Unkown |
| HY-128427 | PLpro-IN-1 | Inhibitor | 99.28% | Unkown |
| HY-128788 | ddhCTP | Inhibitor | / | Unkown |
| HY-131262 | Hydroxychloroquine Impurity E | 99.83% | Unkown | |
| HY-131263 | Hydroxychloroquine Impurity F | / | Unkown | |
| HY-131275 | Imatinib Impurity E | 96.05% | Unkown | |
| HY-131603 | Lamivudine triphosphate | Inhibitor | / | Unkown |
| HY-132280R | Tirilazad (Standard) | Inhibitor | / | Unkown |
| HY-133135 | CHIKV-IN-1 | Inhibitor | / | Unkown |
| HY-133832 | Elopiprazole | Inhibitor | / | Unkown |
| HY-134222AS | N-Acetylserine-d3 | / | Unkown | |
| HY-138794G | XL177A (GMP) | Inhibitor | / | Unkown |
| HY-139165 | AT-9010 | Inhibitor | / | Unkown |
| HY-139732 | SARS-CoV-2-IN-8 | Inhibitor | / | Unkown |
| HY-139866 | SARS-CoV-2-IN-9 | Inhibitor | / | Unkown |
| HY-139892 | XR8-69 | Inhibitor | / | Unkown |
| HY-143417 | SARS-CoV-2-IN-16 | Inhibitor | / | Unkown |
| HY-143418 | SARS-CoV-2-IN-17 | Inhibitor | / | Unkown |
| HY-143467 | SARS-CoV-IN-4 | Inhibitor | / | Unkown |
| HY-143470 | SARS-CoV-2-IN-18 | Inhibitor | / | Unkown |
| HY-144061 | INSCoV-601I(1) | / | Unkown | |
| HY-144062 | INSCoV-614(1B) | / | Unkown | |
| HY-144063 | INSCoV-600K(1) | / | Unkown | |
| HY-144120 | αGalCer-RBD | Inhibitor | / | Unkown |
| HY-144260 | 3CPLro-IN-1 | / | Unkown | |
| HY-144263 | 3CPLro-IN-2 | / | Unkown | |
| HY-144464 | SARS-CoV-2 Mpro-IN-1 | Inhibitor | / | Unkown |
| HY-144623 | Antiviral agent 15 | Inhibitor | / | Unkown |
| HY-144647 | SP inhibitor 1 | Inhibitor | / | Unkown |
| HY-144648 | Mpro/PLpro-IN-1 | / | Unkown | |
| HY-144747 | Hydroxyethylamine | Inhibitor | / | Unkown |
| HY-144798 | FWM-5 | Inhibitor | / | Unkown |
| HY-144799 | FWM-4 | Inhibitor | / | Unkown |
| HY-144833 | SARS-CoV-2 3CLpro-IN-1 | Inhibitor | / | Unkown |
| HY-145276 | SARS-CoV-2-IN-10 | Inhibitor | / | Unkown |
| HY-145277 | SARS-CoV-2-IN-11 | Inhibitor | / | Unkown |
| HY-145435 | SARS-CoV-2-IN-12 | Inhibitor | / | Unkown |
| HY-14588S | (rel)-Lopinavir-d8 | Inhibitor | / | Unkown |
| HY-14588S2 | Lopinavir-d7 | Inhibitor | / | Unkown |
| HY-145949 | Remdesivir de(ethylbutyl 2-aminopropanoate) | / | Unkown | |
| HY-145973 | 3'OMe-m7GpppAmpG | Inhibitor | / | Unkown |
| HY-145973AGL | 3'OMe-m7GpppAmpG ammonium solution (100 mM) (GMP Like) | Inhibitor | / | Unkown |
| HY-145973B | 3'OMe-m7GpppAmpG Tris | Inhibitor | / | Unkown |
| HY-146157 | SARS-CoV-2-IN-22 | Inhibitor | / | Unkown |
| HY-146248 | TFMU-ADPr | / | Unkown | |
| HY-146379 | SARS-CoV-2-IN-19 | Inhibitor | / | Unkown |
| HY-146381 | SARS-CoV-2-IN-20 | Inhibitor | / | Unkown |
| HY-146987 | FWM-3 | Inhibitor | / | Unkown |
| HY-147336 | Desmethylazelastine | / | Unkown | |
| HY-147516 | SARS-CoV-2-IN-21 | Inhibitor | / | Unkown |
| HY-147804 | SARS-CoV-2 3CLpro-IN-3 | Inhibitor | / | Unkown |
| HY-147805 | SARS-CoV-2 3CLpro-IN-4 | Inhibitor | / | Unkown |
| HY-147844 | F8-S43-S3 | Inhibitor | / | Unkown |
| HY-147845 | F8-S40 | Inhibitor | / | Unkown |
| HY-148387 | SARS-CoV-2-IN-35 | Inhibitor | / | Unkown |
| HY-148705 | Isomitomycin A | Inhibitor | / | Unkown |
| HY-149050 | Viral polymerase-IN-1 hydrochloride | Inhibitor | / | Unkown |
| HY-149256 | PLpro/RBD-IN-1 | Inhibitor | / | Unkown |
| HY-149263 | HAA-09 | Inhibitor | / | Unkown |
| HY-149267 | STING agonist-30 | / | Unkown | |
| HY-149304 | SARS-CoV-2-IN-40 | Inhibitor | / | Unkown |
| HY-149314 | SARS-CoV-2-IN-47 | Inhibitor | / | Unkown |
| HY-149315 | SARS-CoV-2-IN-48 | Inhibitor | / | Unkown |
| HY-149317 | ZINC475239213 | Inhibitor | / | Unkown |
| HY-149319 | ZINC61142882 | Inhibitor | / | Unkown |
| HY-149320 | Acryl42-10 | Inhibitor | / | Unkown |
| HY-149322 | Z795161988 | Inhibitor | / | Unkown |
| HY-149368 | SARS-CoV-2-IN-51 | Inhibitor | / | Unkown |
| HY-149655 | D1N8 | Inhibitor | / | Unkown |
| HY-149656 | D1N52 | Inhibitor | / | Unkown |
| HY-149767 | CMX990 | Inhibitor | 96.63% | Unkown |
| HY-149774 | GC-78-HCl | / | Unkown | |
| HY-149868 | SARS-CoV-2-IN-42 | Inhibitor | / | Unkown |
| HY-149940 | SIMR3030 | Inhibitor | / | Unkown |
| HY-149955 | SARS-CoV-2-IN-38 | Inhibitor | / | Unkown |
| HY-150064 | SARS-CoV-2 nsp3-IN-2 | / | Unkown | |
| HY-150258 | TRK-IN-22 | Inhibitor | / | Unkown |
| HY-150322 | SAR-7226 | Inhibitor | / | Unkown |
| HY-150558 | CYP1B1-IN-2 | Inhibitor | / | Unkown |
| HY-150623 | SARS-CoV-2 nsp13-IN-2 | Inhibitor | / | Unkown |
| HY-150624 | SARS-CoV-2 nsp13-IN-3 | Inhibitor | / | Unkown |
| HY-150625 | SARS-CoV-2 nsp13-IN-4 | Inhibitor | / | Unkown |
| HY-150626 | SARS-CoV-2 nsp13-IN-5 | Inhibitor | / | Unkown |
| HY-150632 | SARS-CoV-2 nsp13-IN-6 | Inhibitor | / | Unkown |
| HY-150680 | SARS-CoV-2 nsp14-IN-1 | / | Unkown | |
| HY-150691 | SARS 3CLpro-IN-1 | Inhibitor | / | Unkown |
| HY-150783 | SARS-CoV-2-IN-24 | Inhibitor | / | Unkown |
| HY-150786 | PLP_Snyder530 | Inhibitor | / | Unkown |
| HY-150789 | SARS-CoV-2-IN-23 | Inhibitor | / | Unkown |
| HY-151265 | MMT5-14 | Inhibitor | / | Unkown |
| HY-151267 | SARS-CoV-2-IN-25 | Inhibitor | / | Unkown |
| HY-151267A | SARS-CoV-2-IN-25 disodium | Inhibitor | / | Unkown |
| HY-151269 | SARS-CoV-2-IN-26 | Inhibitor | / | Unkown |
| HY-151269A | SARS-CoV-2-IN-23 disodium | Inhibitor | / | Unkown |
| HY-151271 | SARS-CoV-2-IN-27 | Inhibitor | / | Unkown |
| HY-151271A | SARS-CoV-2-IN-27 disodium | Inhibitor | / | Unkown |
| HY-151274 | SARS-CoV-2-IN-28 | Inhibitor | / | Unkown |
| HY-151274A | SARS-CoV-2-IN-28 disodium | Inhibitor | / | Unkown |
| HY-151276 | SARS-CoV-2-IN-29 | Inhibitor | / | Unkown |
| HY-151276A | SARS-CoV-2-IN-29 disodium | Inhibitor | / | Unkown |
| HY-151278 | SARS-CoV-2-IN-30 | Inhibitor | / | Unkown |
| HY-151278A | SARS-CoV-2-IN-30 disodium | Inhibitor | / | Unkown |
| HY-151474 | SARS-CoV-2-IN-31 | Inhibitor | 99.09% | Unkown |
| HY-151477 | SARS-CoV-2-IN-32 | Inhibitor | 99.58% | Unkown |
| HY-151478 | SARS-CoV-2-IN-33 | Inhibitor | 99.02% | Unkown |
| HY-15148S1 | Tipranavir-d7 | Inhibitor | 98.94% | Unkown |
| HY-15148S2 | Tipranavir-d5 | Inhibitor | / | Unkown |
| HY-151497 | Antimicrobial agent-10 | Inhibitor | / | Unkown |
| HY-151501 | Antimicrobial agent-11 | Inhibitor | / | Unkown |
| HY-151502 | Antimicrobial agent-12 | Inhibitor | / | Unkown |
| HY-151535 | SARS-CoV-2 3CLpro-IN-5 | Inhibitor | / | Unkown |
| HY-151608 | SARS-CoV-2 Mpro-IN-3 | Inhibitor | / | Unkown |
| HY-151900 | SARS-CoV-2 Mpro-IN-4 | Inhibitor | / | Unkown |
| HY-151901 | SARS-CoV-2 Mpro-IN-5 | Inhibitor | / | Unkown |
| HY-151988 | SARS-CoV-2-IN-36 | Inhibitor | / | Unkown |
| HY-151990 | SARS-CoV-2/MERS Mpro-IN-1 | Inhibitor | / | Unkown |
| HY-151991 | SARS-CoV-2/MERS Mpro-IN-2 | Inhibitor | / | Unkown |
| HY-152005 | SARS-CoV-2 3CLpro-IN-6 | Inhibitor | / | Unkown |
| HY-152009 | SARS-CoV-2 3CLpro-IN-7 | Inhibitor | / | Unkown |
| HY-152108 | SARS-CoV-2 Mpro-IN-6 | Inhibitor | / | Unkown |
| HY-152220 | SPR39 | Inhibitor | / | Unkown |
| HY-152222 | SPR38 | Inhibitor | / | Unkown |
| HY-152224 | SPR41 | Inhibitor | / | Unkown |
| HY-152589 | Antiviral agent 25 | Inhibitor | / | Unkown |
| HY-152957 | STING agonist-24 | Agonist | / | Unkown |
| HY-152958 | STING agonist-25 | Agonist | / | Unkown |
| HY-152960 | STING agonist-27 | Agonist | / | Unkown |
| HY-152961 | STING agonist-28 | Agonist | / | Unkown |
| HY-152962 | STING agonist-29 | Agonist | / | Unkown |
| HY-153719 | NSC111552 | Inhibitor | / | Unkown |
| HY-154975 | SARS-CoV-2-IN-49 | Inhibitor | / | Unkown |
| HY-154976 | SARS-CoV-2-IN-50 | Inhibitor | / | Unkown |
| HY-154990 | RdRP-IN-7 | Inhibitor | / | Unkown |
| HY-155013 | SARS-CoV-2-IN-43 | Inhibitor | / | Unkown |
| HY-155014 | SARS-CoV-2-IN-44 | Inhibitor | / | Unkown |
| HY-155015 | SARS-CoV-2-IN-45 | Inhibitor | / | Unkown |
| HY-155016 | SARS-CoV-2-IN-46 | Inhibitor | 99.77% | Unkown |
| HY-155056 | SARS-CoV-2 Mpro-IN-7 | Inhibitor | / | Unkown |
| HY-155057 | SARS-CoV-2 Mpro-IN-8 | Inhibitor | / | Unkown |
| HY-155097 | SARS-CoV-2-IN-53 | Inhibitor | / | Unkown |
| HY-155119 | SARS-CoV-2-IN-54 | Inhibitor | / | Unkown |
| HY-155121 | SARS-CoV-2-IN-56 | Inhibitor | / | Unkown |
| HY-155136 | NSC89641 | Inhibitor | / | Unkown |
| HY-155142 | CDD-1819 | Inhibitor | / | Unkown |
| HY-155143 | CDD-1733 | Inhibitor | / | Unkown |
| HY-155155 | SARS-CoV-2-IN-57 | Inhibitor | / | Unkown |
| HY-155186 | SARS-CoV-2 3CLpro-IN-19 | Inhibitor | / | Unkown |
| HY-155187 | SARS-CoV-2 3CLpro-IN-20 | Inhibitor | 97.09% | Unkown |
| HY-155308 | SARS-CoV-2-IN-61 | Inhibitor | / | Unkown |
| HY-155416 | M56-S2 iodide | Inhibitor | / | Unkown |
| HY-155527 | SARS-CoV-2 Mpro-IN-9 | Inhibitor | 99.31% | Unkown |
| HY-155540 | SARS-CoV-2 3CLpro-IN-14 | Inhibitor | / | Unkown |
| HY-155654 | SARS-CoV-2 Mpro-IN-10 | Inhibitor | / | Unkown |
| HY-155679 | SARS-CoV-2 nsp14-IN-4 | Inhibitor | / | Unkown |
| HY-155734 | SARS-CoV-2-IN-55 | / | Unkown | |
| HY-155979 | SARS-CoV-2 3CLpro-IN-16 | Inhibitor | / | Unkown |
| HY-155980 | SARS-CoV-2 3CLpro-IN-17 | Inhibitor | / | Unkown |
| HY-155981 | SARS-CoV-2 3CLpro-IN-18 | Inhibitor | / | Unkown |
| HY-156008 | SARS-CoV-2-IN-58 | Inhibitor | / | Unkown |
| HY-15602S | Ledipasvir-d6 | Inhibitor | 99.0% | Unkown |
| HY-156325 | SARS-CoV-2-IN-62 | Inhibitor | / | Unkown |
| HY-156337 | SARS-CoV-2-IN-63 | Inhibitor | / | Unkown |
| HY-156441 | SARS-CoV-2-IN-65 | Inhibitor | / | Unkown |
| HY-156459 | SARS-CoV-2 Mpro-IN-12 | Inhibitor | / | Unkown |
| HY-156734 | D-4-77 | Inhibitor | / | Unkown |
| HY-157021 | SARS-CoV-2-IN-66 | Inhibitor | / | Unkown |
| HY-157477 | SARS-CoV-2 3CLpro-IN-22 | Inhibitor | / | Unkown |
| HY-157804 | PROTAC SARS-CoV-2 Mpro degrader-1 | Inhibitor | / | Unkown |
| HY-157805 | PROTAC SARS-CoV-2 Mpro degrader-2 | Degrader | / | Unkown |
| HY-157928 | Keap1-Nrf2-IN-18 | Inhibitor | / | Unkown |
| HY-157966 | SARS-CoV-2 3CLpro-IN-23 | Inhibitor | / | Unkown |
| HY-157996 | CSF1R-IN-21 | Inhibitor | / | Unkown |
| HY-158073 | ML2006a4 | Inhibitor | / | Unkown |
| HY-158347 | SARS-CoV-2 Mpro-IN-15 | Inhibitor | / | Unkown |
| HY-158422 | SARS-CoV-2 Mpro-IN-16 | Inhibitor | / | Unkown |
| HY-158440 | SARS-CoV-2 Mpro-IN-17 | Inhibitor | / | Unkown |
| HY-158569 | SAR114137 | / | Unkown | |
| HY-15957 | FASN-IN-7 | Inhibitor | / | Unkown |
| HY-159633 | PLpro-IN-5 | Inhibitor | / | Unkown |
| HY-159655 | PLpro-IN-6 | Inhibitor | / | Unkown |
| HY-159890 | MTI013 | Inhibitor | / | Unkown |
| HY-161238 | SARS-CoV-2-IN-79 | Inhibitor | / | Unkown |
| HY-161245 | FGA146 | Inhibitor | / | Unkown |
| HY-161261 | SARS-CoV-2-IN-81 | Inhibitor | / | Unkown |
| HY-161365 | PLpro-IN-2 | Inhibitor | / | Unkown |
| HY-161371 | VD5123 | Inhibitor | / | Unkown |
| HY-161722 | SARS-CoV-2 Mpro-IN-21 | Inhibitor | / | Unkown |
| HY-161790 | Mpro ligand 1 | / | Unkown | |
| HY-161791 | Mpro ligand 2 | / | Unkown | |
| HY-161793 | (S,R,S)-AHPC-NHCO-C-O-C5-N3 | / | Unkown | |
| HY-161844 | Virapinib | / | Unkown | |
| HY-161919 | SARS-CoV-2 3CLpro-IN-25 | Inhibitor | / | Unkown |
| HY-162151 | SARS-CoV-2-IN-74 | Inhibitor | / | Unkown |
| HY-162154 | SARS-CoV-2-IN-75 | Inhibitor | / | Unkown |
| HY-162229 | GRL-190-21 | Inhibitor | / | Unkown |
| HY-162236 | SARS-CoV-2-IN-80 | Inhibitor | / | Unkown |
| HY-162295 | SARS-CoV-2-IN-83 | Inhibitor | / | Unkown |
| HY-162414 | SARS-CoV-2-IN-84 | Inhibitor | / | Unkown |
| HY-162464 | MPD2 | Inhibitor | / | Unkown |
| HY-162474 | BZG2 | Inhibitor | / | Unkown |
| HY-162504 | 2'-RIBOTAC-U | Inhibitor | / | Unkown |
| HY-162507 | 2'-RIBOTAC-U recruiter-linker | / | Unkown | |
| HY-162701 | Antiviral agent 58 | Inhibitor | / | Unkown |
| HY-162725 | TLR7 agonist 24 | Agonist | / | Unkown |
| HY-162777 | SARS-CoV-2-IN-93 | Inhibitor | / | Unkown |
| HY-162790 | SARS-CoV-2-IN-95 | Inhibitor | / | Unkown |
| HY-162914 | SARS-CoV-2-IN-96 | Inhibitor | / | Unkown |
| HY-162924 | SARS-CoV-IN-6 | Inhibitor | / | Unkown |
| HY-162956 | SARS-CoV-2-IN-97 | Inhibitor | / | Unkown |
| HY-163389 | Mpro/Cathepsin L-IN-1 | Inhibitor | / | Unkown |
| HY-163614 | SARS-CoV-2-IN-87 | Inhibitor | / | Unkown |
| HY-163706 | SARS-CoV-2-IN-88 | Inhibitor | / | Unkown |
| HY-163785 | 1"-α-Azido-RDPr | Inhibitor | / | Unkown |
| HY-163857 | SARS-CoV-2-IN-91 | Inhibitor | / | Unkown |
| HY-163912 | JZD-07 | Inhibitor | / | Unkown |
| HY-167960 | BrAc-Galactose-Sar-N-Me-alanine-DM1 | / | Unkown | |
| HY-168107 | SARS-CoV-2-IN-98 | Inhibitor | / | Unkown |
| HY-168152 | SARS-CoV-2 3CLpro-IN-26 | Inhibitor | / | Unkown |
| HY-168259 | PLpro-IN-8 | Inhibitor | / | Unkown |
| HY-168430 | SARS-CoV-2 3CLpro-IN-30 | Inhibitor | / | Unkown |
| HY-168441 | NCGC00537446 | Inhibitor | / | Unkown |
| HY-168455 | RNAse L RIBOTAC | / | Unkown | |
| HY-168557 | SARS-CoV-2-IN-101 | Inhibitor | / | Unkown |
| HY-168564 | SARS-CoV-2 3CLpro-IN-27 | Inhibitor | / | Unkown |
| HY-168568 | SARS-CoV-2 Mpro-IN-28 | Inhibitor | / | Unkown |
| HY-168599 | SARS-CoV-2 Mpro-IN-31 | Inhibitor | / | Unkown |
| HY-168600 | SARS-CoV-2 Mpro-IN-32 | Inhibitor | / | Unkown |
| HY-168916 | Jun13296 | Inhibitor | / | Unkown |
| HY-169055 | SARS-CoV-2 Mpro-IN-25 | Inhibitor | / | Unkown |
| HY-169224 | SARS-CoV-2-IN-100 | Inhibitor | / | Unkown |
| HY-169256 | ZINC4497834 | Inhibitor | / | Unkown |
| HY-169260 | SARS-CoV-2 Mpro-IN-27 | Inhibitor | / | Unkown |
| HY-169340 | SAR-150640 | Agonist | / | Unkown |
| HY-169405 | AAK1/HDACs-IN-1 | Inhibitor | / | Unkown |
| HY-169410 | SARS-CoV-2 3CLpro-IN-29 | Inhibitor | / | Unkown |
| HY-169419 | SARS-CoV-2-IN-108 | Inhibitor | / | Unkown |
| HY-169847 | ZK-806450 | / | Unkown | |
| HY-169977 | CKP-25 | Inhibitor | / | Unkown |
| HY-169997 | LU9 | Inhibitor | / | Unkown |
| HY-170309 | NZ-804 | Inhibitor | / | Unkown |
| HY-170357 | SARS-CoV-2 3CLpro-IN-28 | Inhibitor | / | Unkown |
| HY-17042AS1 | Cetirizine-d8 dihydrochloride | Antagonist | 99.64% | Unkown |
| HY-170515A | (E),(Z)-RNF5 agonist 1 | / | Unkown | |
| HY-170523 | RU-0415529 | Inhibitor | / | Unkown |
| HY-170598 | HP211206 | Inhibitor | / | Unkown |
| HY-170767 | SARS-CoV-2-IN-109 | Inhibitor | / | Unkown |
| HY-170799 | HNC-1664 | Inhibitor | / | Unkown |
| HY-171781 | FL-166 | Inhibitor | / | Unkown |
| HY-172214 | AB-343 | Inhibitor | / | Unkown |
| HY-172265 | FKBP12 PROTAC FM4 | Degrader | 99.95% | Unkown |
| HY-172350 | WEHI-P8 | Inhibitor | / | Unkown |
| HY-172960 | SARS-CoV-2 Mpro-IN-44 | Inhibitor | / | Unkown |
| HY-172965 | SARS-CoV-2 Mpro-IN-43 | / | Unkown | |
| HY-173411 | DNJ-20 | Inhibitor | / | Unkown |
| HY-17367S4 | Atazanavir-d6 | 99.28% | Unkown | |
| HY-174224 | Amb929 | Inhibitor | / | Unkown |
| HY-174233 | PROTAC SARS-CoV-2 Mpro degrader-4 | Degrader | / | Unkown |
| HY-174235 | Thalidomide-OCH2-amide-PEG2-C2-Boc | / | Unkown | |
| HY-17430S1 | Amprenavir-d4-1 | Inhibitor | / | Unkown |
| HY-174350 | CK2-IN-15 | Inhibitor | / | Unkown |
| HY-174370 | MePT-S-N-Pme | Inhibitor | / | Unkown |
| HY-174373 | SARS-CoV-2-IN-113 | Inhibitor | / | Unkown |
| HY-175344 | TMP1 | Inhibitor | / | Unkown |
| HY-175461 | AVI-4206 | Inhibitor | / | Unkown |
| HY-17589S | Chloroquine-d5 diphosphate | Inhibitor | / | Unkown |
| HY-176211 | SARS-CoV-2 Mpro-IN-45 | Inhibitor | / | Unkown |
| HY-176264 | DNDI-6510 | Inhibitor | / | Unkown |
| HY-176440 | BP-198 | / | Unkown | |
| HY-177303 | AXT-914 | Inhibitor | 98.83% | Unkown |
| HY-177663 | SARSi-4 sodium | Inhibitor | / | Unkown |
| HY-177884 | Triptolide-6-β-D-glucose | / | Unkown | |
| HY-177885 | Triptolide-6-methoxy-β-D-glucose | / | Unkown | |
| HY-178025 | TDI-014925 | Inhibitor | / | Unkown |
| HY-178135 | SCR005 | Inhibitor | / | Unkown |
| HY-178137 | SCR007 | Inhibitor | / | Unkown |
| HY-178156 | DHODH-IN-31 | Inhibitor | 99.55% | Unkown |
| HY-178160 | SARS-CoV-2 PLpro-IN-2 | Inhibitor | / | Unkown |
| HY-178374 | BACE-1/Mpro-IN-1 | Inhibitor | / | Unkown |
| HY-178772 | SARS-CoV-2 Mpro-IN-50 | Inhibitor | / | Unkown |
| HY-179088 | AVI-6451 | Inhibitor | / | Unkown |
| HY-179249 | Fluoroneplanocin A-8N | Inhibitor | / | Unkown |
| HY-179269 | SARS-CoV-2 nsp14-IN-9 | Inhibitor | / | Unkown |
| HY-179283 | PROTAC SARS-CoV-2 RdRp Degrader-1 | / | Unkown | |
| HY-179293 | SARS-CoV-2 PLpro-IN-3 | Inhibitor | / | Unkown |
| HY-179334 | DMA-155 | Inhibitor | / | Unkown |
| HY-179556 | SARS-CoV-2 nsp14-IN-10 | / | Unkown | |
| HY-179567 | NVP-EGT710 | Inhibitor | / | Unkown |
| HY-179617 | Cbl-b-IN-30 | Inhibitor | / | Unkown |
| HY-179634 | ASF-006 sodium | Inhibitor | / | Unkown |
| HY-179703 | FXR agonist 15 | Agonist | / | Unkown |
| HY-180194 | SERCA2a activator 2 | Activator | / | Unkown |
| HY-180318 | MI-30 | Inhibitor | / | Unkown |
| HY-180332 | NSC-624871 | Inhibitor | / | Unkown |
| HY-180405 | UAWJ-247 | Inhibitor | / | Unkown |
| HY-180578 | MWAC-3429 | Inhibitor | / | Unkown |
| HY-180792 | CK-571 | Inhibitor | / | Unkown |
| HY-180816 | PRMT5-MTA-IN-7 | Inhibitor | / | Unkown |
| HY-181033 | (M)-AVI-4773 | Inhibitor | / | Unkown |
| HY-181066 | ACE2-SP PPI-IN-1 | Inhibitor | / | Unkown |
| HY-181263 | Jun13698 | Inhibitor | / | Unkown |
| HY-181352 | SB-140 | Inhibitor | / | Unkown |
| HY-181489 | SARS-CoV-2 3CLpro-IN-35 | Inhibitor | / | Unkown |
| HY-181606 | Cyclo(phg-isoDGR-k)-PEG4-non-cleavable-SAR405838 | / | Unkown | |
| HY-181661 | YL1004 | Inhibitor | / | Unkown |
| HY-181778 | RdRP-IN-10 | Inhibitor | / | Unkown |
| HY-181904 | SARS-CoV-2 Mpro ligand 2 | Ligand | / | Unkown |
| HY-181905 | (S,R,S)-AHPC-Me-C2-piperazine | / | Unkown | |
| HY-181983 | VPC285785 | Inhibitor | / | Unkown |
| HY-182024 | SARS-CoV-2 3CLpro-IN-36 | Inhibitor | / | Unkown |
| HY-182065 | SARS-CoV-2 Mpro-IN-56 | Inhibitor | / | Unkown |
| HY-182252 | SAR296968 | Inhibitor | / | Unkown |
| HY-182894 | MR1-114 | Inhibitor | / | Unkown |
| HY-182913 | SARS-CoV-2-IN-122 | Inhibitor | / | Unkown |
| HY-183185 | BZ-30 | Inhibitor | / | Unkown |
| HY-183266 | SR-A-174 | Inhibitor | / | Unkown |
| HY-183752 | CG-0988 | Inhibitor | / | Unkown |
| HY-183761 | Antiviral agent 86 | Inhibitor | / | Unkown |
| HY-183940 | Cathepsin L-IN-7 | Inhibitor | / | Unkown |
| HY-184146 | AD05 | Inhibitor | / | Unkown |
| HY-184147 | AD06 | Inhibitor | / | Unkown |
| HY-184171 | mCMX110 | Inhibitor | / | Unkown |
| HY-184248 | FM-74-103 | Inhibitor | / | Unkown |
| HY-18986S | SAR405838-d10 | / | Unkown | |
| HY-19195 | TO-195 (hydrochlorid) | Inhibitor | / | Unkown |
| HY-203876 | Sar10 | / | Unkown | |
| HY-44484 | MAC-5576 | / | Unkown | |
| HY-90001S1 | Ritonavir-13C,d3 | / | Unkown | |
| HY-90001S2 | Ritonavir-d8 | / | Unkown | |
| HY-B0462AS | Azelastine-13C,d3 | / | Unkown | |
| HY-B0462B | (S)-Azelastine hydrochloride | / | Unkown | |
| HY-B0462S | Azelastine-13C,d3 hydrochloride | / | Unkown | |
| HY-B1370S | Hydroxychloroquine-d4 sulfate | Inhibitor | / | Unkown |
| HY-B1624C | Debrisoquin hydrobromide | Inhibitor | / | Unkown |
| HY-B2074 | Demexiptiline | Ligand | / | Unkown |
| HY-D2342 | SARS-CoV-2 3CLpro probe-1 | / | Unkown | |
| HY-E70610 | SARS-CoV-2 main protease | / | Unkown | |
| HY-G0017A | N-Desmethyl imatinib mesylate | / | Unkown | |
| HY-G0017R | N-Desmethyl imatinib (Standard) | / | Unkown | |
| HY-G0017S1 | N-Desmethyl imatinib-d4 | / | Unkown | |
| HY-N10118 | NK007 | Inhibitor | / | Unkown |
| HY-N10604 | Dihydromaniwamycin E | Inhibitor | / | Unkown |
| HY-N10605 | Maniwamycin E | Inhibitor | / | Unkown |
| HY-N10661 | Ipomoeassin F | Inhibitor | / | Unkown |
| HY-N11896A | 10-Hydroxyaloin A | Inhibitor | / | Unkown |
| HY-N14351 | Ferrocin A | Inhibitor | / | Unkown |
| HY-N144101 | SARS-CoV MPro-IN-2 | Inhibitor | / | Unkown |
| HY-N15365 | Antcin B | Inhibitor | / | Unkown |
| HY-N16586 | Apigenin 7,4'-di-O-alloside | Inhibitor | / | Unkown |
| HY-N1836 | 3-Acetonyl-3-hydroxyoxindole | Inhibitor | / | Unkown |
| HY-N7378A | N-Hydroxypipecolic acid potassium | / | Unkown | |
| HY-N9664 | Crepidiaside B | Inhibitor | / | Unkown |
| HY-P10344 | MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 | / | Unkown | |
| HY-P10466 | KZR-8445 | Inhibitor | / | Unkown |
| HY-P10466A | KZR-8445 TFA | Inhibitor | / | Unkown |
| HY-P10555 | (D-Arg2, Sar 4)-Dermorphin (1-4) | Agonist | / | Unkown |
| HY-P10640 | [Sar1,Thr8]-Angiotensin II | Antagonist | / | Unkown |
| HY-P10688 | NQK-Q8 peptide | / | Unkown | |
| HY-P10803 | FLDKFNHEAEDLFYQSSL | Inhibitor | / | Unkown |
| HY-P10855 | S1b3inL1 | Inhibitor | / | Unkown |
| HY-P10858 | UCI-1 | Inhibitor | / | Unkown |
| HY-P10872 | P315V3 | Inhibitor | / | Unkown |
| HY-P10975 | P9R | Inhibitor | / | Unkown |
| HY-P10976 | Spike Glycoprotein (1147-1162) | Inhibitor | / | Unkown |
| HY-P11012 | EK1 | Inhibitor | / | Unkown |
| HY-P11389 | (Sar1,Gly8)-Angiotensin II | Antagonist | / | Unkown |
| HY-P11464 | SARS-CoV-2 Spike receptor binding domain, RBD (371-394) | / | Unkown | |
| HY-P11470 | Conofurin-Delta | Inhibitor | / | Unkown |
| HY-P11579 | TLP-3 | Inhibitor | / | Unkown |
| HY-P2296 | Abz-FRLKGGAPIKGV-EDDNP TFA | / | Unkown | |
| HY-P3258 | SP-10 | / | Unkown | |
| HY-P3905 | [Glp5,Sar9] Substance P (5-11) | / | Unkown | |
| HY-P3927 | [MePhe8,Sar9] Substance P | / | Unkown | |
| HY-P3932 | [Sar4] Substance P (4-11) | / | Unkown | |
| HY-P4296 | H-Gly-Sar-Sar-OH | / | Unkown | |
| HY-P4307 | Antioxidant agent-9 | Inhibitor | / | Unkown |
| HY-P4475 | Sar-Pro-Arg-pNA | / | Unkown | |
| HY-P5168AS | GPSVFPLAPSSK-13C6,15N2 TFA | Inhibitor | / | Unkown |
| HY-P5398 | HR2-18 | Inhibitor | / | Unkown |
| HY-P5522 | TriDAP | / | Unkown | |
| HY-P5642 | Retrocyclin-101 | Inhibitor | / | Unkown |
| HY-P5827 | SBP1 peptide | / | Unkown | |
| HY-P5975 | Z-Leu-Leu-Leu-fluoromethyl ketone | Inhibitor | / | Unkown |
| HY-RS12443 | SAR1B Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12448 | SARS1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12449 | SARS2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W031727S1 | Hydroxychloroquine-d5 | / | Unkown | |
| HY-W096127 | Biotin-sar-oh | / | Unkown | |
| HY-W348072 | SARS-CoV-2-IN-59 | Inhibitor | / | Unkown |
| HY-W423489 | SARS-CoV-2-IN-76 | Inhibitor | / | Unkown |
| HY-W699983 | Imidazole-15N2 | Inhibitor | 98.56% | Unkown |
| HY-W707562 | FOY 251-d4 | / | Unkown | |
| HY-W744206 | Azelastine-d3 | / | Unkown | |
| HY-W760546 | SARS-CoV-2 3CLpro-IN-15 | Inhibitor | / | Unkown |
| HY-W777545 | 4-[(7-Chloro-4-quinolinyl)amino]-1-pentanol-d4 | / | Unkown | |
| HY-W816575 | MDI-403 | / | Unkown | |
| HY-100442S | Paquinimod-d5 | Inhibitor | / | Unkown |
| HY-100661 | Cetirizine Impurity D | Antagonist | / | Unkown |
| HY-101823A | A-81282 | Antagonist | / | Unkown |
| HY-108325S | Brequinar-d3 | Inhibitor | / | Unkown |
| HY-109037S | Mavacamten-d6 | Modulator | / | Unkown |
| HY-109037S2 | Mavacamten-d1 | Modulator | / | Unkown |
| HY-111074 | DB12055 | Inhibitor | / | Unkown |
| HY-112905 | AN11736 | Inhibitor | / | Unkown |
| HY-116143 | MAGL-IN-12 | Inhibitor | / | Unkown |
| HY-119980BS | Fluphenazine-d6 hydrochloride | / | Unkown | |
| HY-121020 | Arcapillin | Inhibitor | / | Unkown |
| HY-123185 | (Rac)-Z-FA-FMK | Inhibitor | / | Unkown |
| HY-12530S1 | Velpatasvir-d3 | Inhibitor | / | Unkown |
| HY-12605S | SAR107375-d11 Tartrate | Inhibitor | / | Unkown |
| HY-133828 | Cinanserin | / | Unkown | |
| HY-136967 | Mergocriptine | / | Unkown | |
| HY-138687S1 | Nirmatrelvir-d6 | Inhibitor | / | Unkown |
| HY-139111 | Oxocarbazate | Inhibitor | / | Unkown |
| HY-139355 | (S)-GS-621763 | Control | / | Unkown |
| HY-14588S1 | Lopinavir-d8 | Inhibitor | / | Unkown |
| HY-14909R | Bardoxolone (Standard) | / | Unkown | |
| HY-149649 | SARS-CoV-2-IN-64 | Inhibitor | / | Unkown |
| HY-149799 | 28-O-Imidazolyl-azepano-betulin | Inhibitor | / | Unkown |
| HY-15463S3 | Imatinib-13C,d3 | / | Unkown | |
| HY-155601 | SARS-CoV-2-IN-52 | Inhibitor | / | Unkown |
| HY-156007 | SARS-CoV-2 3CLpro-IN-21 | Inhibitor | / | Unkown |
| HY-15602S1 | Ledipasvir-d16 | Inhibitor | / | Unkown |
| HY-157022 | SARS-CoV-2-IN-67 | Inhibitor | / | Unkown |
| HY-157144 | SARS-CoV-2-IN-68 | Inhibitor | / | Unkown |
| HY-157145 | SARS-CoV-2-IN-69 | Inhibitor | / | Unkown |
| HY-157305 | Jun11165 | Inhibitor | / | Unkown |
| HY-157439 | SARS-CoV-2-IN-72 | Inhibitor | / | Unkown |
| HY-157539 | PB49673382 | Inhibitor | / | Unkown |
| HY-157848 | SARS-CoV-2-IN-82 | Inhibitor | / | Unkown |
| HY-158687 | SARS-CoV-2 Mpro-IN-18 | Inhibitor | / | Unkown |
| HY-158751 | Jun9-72-2 | Inhibitor | / | Unkown |
| HY-158763 | MPI8 | Inhibitor | / | Unkown |
| HY-158905 | MTDB-Alkyne | Degrader | / | Unkown |
| HY-159477 | SARS-CoV-2-IN-92 | Inhibitor | / | Unkown |
| HY-159911 | SARS-CoV-2 Mpro-IN-29 | Inhibitor | / | Unkown |
| HY-159932 | SARS-CoV-2 Mpro-IN-30 | Inhibitor | / | Unkown |
| HY-159933 | SARS-CoV-2-IN-105 | Inhibitor | / | Unkown |
| HY-159961 | SARS-CoV-2 Mpro-IN-34 | Inhibitor | / | Unkown |
| HY-159985 | Jun13728 | Inhibitor | / | Unkown |
| HY-160943 | F594-1001 | Inhibitor | / | Unkown |
| HY-160943A | F594-1001 hydrochloride | Inhibitor | / | Unkown |
| HY-161068 | hACE2/SP-IN-1 | Inhibitor | / | Unkown |
| HY-161070 | Antiviral agent 46 | Inhibitor | / | Unkown |
| HY-161114 | MDOLL-0229 | Inhibitor | / | Unkown |
| HY-161729 | PLpro-IN-3 | Inhibitor | / | Unkown |
| HY-161777 | SARS-CoV-2 Mpro-IN-23 | Inhibitor | / | Unkown |
| HY-161789 | PROTAC SARS-CoV-2 Mpro degrader-3 | Inhibitor | / | Unkown |
| HY-161792 | N3-C5-O-C-Boc | / | Unkown | |
| HY-161837 | SARS-CoV-2 Mpro-IN-24 | Inhibitor | / | Unkown |
| HY-162111 | SARS-CoV-2-IN-73 | Inhibitor | / | Unkown |
| HY-162550 | Jobosic acid | Inhibitor | / | Unkown |
| HY-162598 | CET-1 | Inhibitor | / | Unkown |
| HY-162604 | SARS-CoV-2-IN-90 | Inhibitor | / | Unkown |
| HY-162674 | MERS-CoV-IN-2 | Inhibitor | / | Unkown |
| HY-162719 | RH12 | Inhibitor | / | Unkown |
| HY-162984 | SARS-CoV-2-IN-99 | Inhibitor | / | Unkown |
| HY-163029 | CTSL/B-IN-1 | Inhibitor | / | Unkown |
| HY-163067 | SARS-CoV-2-IN-71 | Inhibitor | / | Unkown |
| HY-163186 | SARS-CoV-2 Mpro-IN-13 | Inhibitor | / | Unkown |
| HY-163206 | SARS-CoV-2-IN-77 | Inhibitor | / | Unkown |
| HY-163211 | SARS-CoV-2 Mpro-IN-14 | Inhibitor | / | Unkown |
| HY-163627 | SARS-CoV-2 Mpro-IN-19 | Inhibitor | / | Unkown |
| HY-163628 | SARS-CoV-2 Mpro-IN-20 | Inhibitor | / | Unkown |
| HY-163713 | SARS-CoV-2-IN-89 | Inhibitor | / | Unkown |
| HY-163783 | CSNK2-IN-1 | Inhibitor | / | Unkown |
| HY-163908 | SARS-CoV-2-IN-94 | Inhibitor | / | Unkown |
| HY-163913 | SARS-CoV-IN-5 | Inhibitor | / | Unkown |
| HY-164868 | SARS-CoV-2-IN-106 | Inhibitor | / | Unkown |
| HY-166878S | SAR107375E impurity 13-d8 | / | Unkown | |
| HY-166879S | SAR107375E Impurity 14-d8 | / | Unkown | |
| HY-168456 | RNA recruiter 1 | / | Unkown | |
| HY-168458 | RNA recruiter-linker 1 | / | Unkown | |
| HY-168472 | 13-TP prodrug | Inhibitor | / | Unkown |
| HY-168473 | 13-TP | Inhibitor | / | Unkown |
| HY-168584 | SARS-CoV-2-IN-102 | Inhibitor | / | Unkown |
| HY-168917 | 9-Aminominocycline | Inhibitor | / | Unkown |
| HY-169012 | PSB-21110 | Inhibitor | / | Unkown |
| HY-169200 | SARS-CoV-2 Mpro-IN-26 | Inhibitor | / | Unkown |
| HY-169220S | RORγ/DHODH-IN-1 | Inhibitor | / | Unkown |
| HY-169222S | RORγ/DHODH-IN-2 | Inhibitor | / | Unkown |
| HY-169501 | WIN 62577 | / | Unkown | |
| HY-169974 | SARS-CoV-2-IN-107 | Inhibitor | / | Unkown |
| HY-169998 | XJ5 | Inhibitor | / | Unkown |
| HY-170399 | SARS-CoV-2 PLpro-IN-1 | Inhibitor | / | Unkown |
| HY-170504 | ZHAWOC25153 | Inhibitor | / | Unkown |
| HY-170545 | SARS-CoV-2 Mpro-IN-35 | Inhibitor | / | Unkown |
| HY-170599 | H117 | Inhibitor | 99.27% | Unkown |
| HY-170819 | VK13 | Inhibitor | / | Unkown |
| HY-170886 | SARS-CoV-2 Mpro-IN-36 | Inhibitor | / | Unkown |
| HY-170922 | SARS-CoV-2-IN-110 | Inhibitor | / | Unkown |
| HY-171189 | C-467929 | Inhibitor | / | Unkown |
| HY-172223 | 3-Deazaguanosine | Inhibitor | / | Unkown |
| HY-173134 | SARS-CoV-2 RdRp-IN-1 | Inhibitor | / | Unkown |
| HY-173148 | TKB272 | Inhibitor | / | Unkown |
| HY-173285 | SARS-CoV-2 Mpro-IN-38 | Inhibitor | / | Unkown |
| HY-173305 | Mpro/PLPro-IN-2 | Inhibitor | / | Unkown |
| HY-173362 | SARS-CoV-2 Mpro-IN-39 | Inhibitor | / | Unkown |
| HY-173421 | (H)S(OMe)-DFR-kbt | Inhibitor | / | Unkown |
| HY-173426 | SARS-CoV-2 Mpro-IN-40 | Inhibitor | / | Unkown |
| HY-173459 | N-0920 | Inhibitor | / | Unkown |
| HY-173485 | SARS-CoV-2 Mpro-IN-41 | Inhibitor | / | Unkown |
| HY-173511 | SARS-CoV-2 nsp13-IN-7 | Inhibitor | / | Unkown |
| HY-173514 | SARS-CoV-2 Mpro-IN-42 | Inhibitor | / | Unkown |
| HY-173575 | SARS-CoV-2 3CLpro-IN-31 | Inhibitor | / | Unkown |
| HY-17367S5 | Atazanavir-d24 | / | Unkown | |
| HY-174251 | (±)-Tuaimenal A | Inhibitor | / | Unkown |
| HY-174258 | ATPase-IN-6 | Inhibitor | / | Unkown |
| HY-17430S2 | Amprenavir-13C6 | Inhibitor | / | Unkown |
| HY-174320 | SARS-CoV-2-IN-112 | Inhibitor | / | Unkown |
| HY-174385 | SARS-CoV-2-IN-114 | Inhibitor | / | Unkown |
| HY-174402 | PLpro-IN-9 | Inhibitor | / | Unkown |
| HY-174439 | Nsp12-IN-2 | Inhibitor | / | Unkown |
| HY-175015 | SARS-CoV-2 Mpro-IN-46 | Inhibitor | / | Unkown |
| HY-175024 | MC12 | Inhibitor | / | Unkown |
| HY-17517 | Tiadinil | Inhibitor | 99.84% | Unkown |
| HY-175325 | SARS-CoV-2-IN-116 | Inhibitor | / | Unkown |
| HY-175460 | SARS-CoV-2-IN-117 | Inhibitor | / | Unkown |
| HY-175475 | MolPort-010-778-422 | Inhibitor | / | Unkown |
| HY-175499 | SARS-CoV-2-IN-118 | Inhibitor | / | Unkown |
| HY-175697 | Glycosyltransferase-IN-2 | Inhibitor | / | Unkown |
| HY-175712 | SARS-CoV-2 Mpro-IN-47 | Inhibitor | / | Unkown |
| HY-175829 | SARS-CoV-2-IN-119 | Inhibitor | / | Unkown |
| HY-176229 | Mpro/Cathepsin L-IN-2 | Inhibitor | / | Unkown |
| HY-176232 | BBH-4 | Inhibitor | / | Unkown |
| HY-176280 | SARS-CoV-2-IN-115 | Inhibitor | / | Unkown |
| HY-176414 | SARS-CoV-2-IN-111 | Inhibitor | / | Unkown |
| HY-176441 | E3 ligase Ligand 66 | / | Unkown | |
| HY-176442 | SARS-CoV-2 Mpro ligand 1 | Inhibitor | / | Unkown |
| HY-177332 | SLC-391 | Inhibitor | / | Unkown |
| HY-178027 | SARS-CoV-2 nsp14-IN-6 | Inhibitor | / | Unkown |
| HY-178027A | SARS-CoV-2 nsp14-IN-6 ammonium | Inhibitor | / | Unkown |
| HY-178188 | TPG-20A | Inhibitor | / | Unkown |
| HY-178318 | LRH-0003 | Inhibitor | / | Unkown |
| HY-178435 | SARS-CoV-2 Mpro-IN-48 | Inhibitor | / | Unkown |
| HY-178439 | SARS-CoV-2 3CLpro-IN-33 | Inhibitor | / | Unkown |
| HY-178445 | PI3Kδ-IN-27 | Inhibitor | / | Unkown |
| HY-178480 | SARS-CoV-2 Mpro-IN-49 | Inhibitor | / | Unkown |
| HY-178695 | E3 Ligase Ligand-linker Conjugate 216 | / | Unkown | |
| HY-178696 | UAWJ9-36-3 | Inhibitor | / | Unkown |
| HY-179048 | MH44 | Inhibitor | / | Unkown |
| HY-179097 | SARS-CoV-2 nsp14-IN-8 | / | Unkown | |
| HY-179102 | SARS-CoV-2 Mpro-IN-51 | Inhibitor | / | Unkown |
| HY-179419 | Glucokinase activator 10 | Activator | / | Unkown |
| HY-179612 | SARS-CoV-2 3CLpro-IN-34 | Inhibitor | / | Unkown |
| HY-179708 | Cbz-QFR-kbt | Inhibitor | / | Unkown |
| HY-180126 | SARS-CoV-2 nsp14-IN-11 | / | Unkown | |
| HY-180129 | SARS-CoV-2-IN-120 | Inhibitor | / | Unkown |
| HY-180229 | GK730 | Inhibitor | / | Unkown |
| HY-180369 | SIMR-2418 | Inhibitor | / | Unkown |
| HY-180387 | UAWJ246 | Inhibitor | / | Unkown |
| HY-180458 | SARS-CoV-2 Mpro-IN-52 | Inhibitor | / | Unkown |
| HY-180510 | BFC220 | Inhibitor | / | Unkown |
| HY-180516 | BFC204 | Inhibitor | / | Unkown |
| HY-180673 | Mpro/RdRp-IN-1 | Inhibitor | / | Unkown |
| HY-180778 | Insecticidal agent 28 | Inhibitor | / | Unkown |
| HY-180791 | SARS-CoV-2-IN-121 | Inhibitor | / | Unkown |
| HY-180812 | Antibacterial agent 312 | Inhibitor | / | Unkown |
| HY-180910 | SARS-CoV-2 Mpro-IN-53 | Inhibitor | / | Unkown |
| HY-181154 | PROTAC SARS-CoV-2 Mpro degrader-5 | Degrader | / | Unkown |
| HY-181162 | SARS-CoV-2 Mpro-IN-54 | Inhibitor | / | Unkown |
| HY-181165 | SB2960 | Inhibitor | / | Unkown |
| HY-181176 | DEMAMP | / | Unkown | |
| HY-181192 | PROTAC SARS-CoV-2 Mpro degrader-6 | Degrader | / | Unkown |
| HY-181193 | PROTAC SARS-CoV-2 Mpro degrader-7 | Degrader | / | Unkown |
| HY-181249 | SARS-CoV-2 Mpro-IN-55 | Inhibitor | / | Unkown |
| HY-181262 | SARS-CoV-2 PLpro-IN-4 | Inhibitor | / | Unkown |
| HY-181641 | SARS-CoV-2 PLpro-IN-6 | Inhibitor | / | Unkown |
| HY-181870 | PROTAC SARS-CoV-2 Mpro degrader-8 | Degrader | / | Unkown |
| HY-181927 | SARS-CoV-2 PLpro-IN-7 | Inhibitor | / | Unkown |
| HY-182292 | SARS-CoV-2 3CLpro-IN-37 | / | Unkown | |
| HY-182425 | MI-23 | Inhibitor | / | Unkown |
| HY-182428 | UAWJ248 | Inhibitor | / | Unkown |
| HY-182754 | SARS-CoV-2 Mpro-IN-57 | Inhibitor | / | Unkown |
| HY-183661 | SCHEMBL12616233 | Inhibitor | / | Unkown |
| HY-183727 | SARS-CoV-2 Mpro-IN-59 | Inhibitor | / | Unkown |
| HY-184269 | SARS-CoV-2 3CLpro-IN-38 | Inhibitor | / | Unkown |
| HY-19344S | Lifitegrast-d4 | / | Unkown | |
| HY-19344S1 | Lifitegrast-d6 | / | Unkown | |
| HY-19344S2 | Lifitegrast-d4-1 | Antagonist | / | Unkown |
| HY-32717 | DH03 | / | Unkown | |
| HY-90001S3 | rel-Ritonavir-d6 | 98.66% | Unkown | |
| HY-B0157S1 | Ketotifen-d3 | Inhibitor | / | Unkown |
| HY-B0689S1 | Indinavir-13C4,15N | / | Unkown | |
| HY-N0886R | Aloin B (Standard) | Inhibitor | / | Unkown |
| HY-N12384 | (25S)-Antcin B | Inhibitor | / | Unkown |
| HY-N15268 | Koenine | Inhibitor | / | Unkown |
| HY-N18500 | (+)-Adlumidine | Inhibitor | / | Unkown |
| HY-N3445 | Jaceidin triacetate | Inhibitor | / | Unkown |
| HY-P5407 | HD5 | Inhibitor | / | Unkown |
| HY-RS20487 | Sar1a Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26995 | Sar1a Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W012531S2 | 2-Hydroxycinnamic acid-d4 | Inhibitor | / | Unkown |
| HY-W098721 | Z-Gly-Sar-OH | / | Unkown | |
| HY-W108137 | Boc-Gly-Sar-OH | / | Unkown | |
| HY-W140555 | 5,7-Dimethoxyphthalide | Inhibitor | 99.97% | Unkown |
| HY-W217676 | SARS-CoV-2 Mpro-IN-58 | / | Unkown | |
| HY-W614623 | (S)-ML188 | Inhibitor | / | Unkown |
| HY-W653745 | 6-Thioguanine-13C2,15N | / | Unkown | |
| HY-W653853 | Ritonavir-13C3 | / | Unkown | |
| HY-W728005 | Covidcil-19 | Inhibitor | / | Unkown |
| HY-W749691 | (S)-Velpatasvir-13c,d3 | Inhibitor | / | Unkown |
| HY-W753281 | Dexamethasone metasulfobenzoate sodium | Inhibitor | / | Unkown |
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990907 | Brivekimig | Inhibitor | 98% | Unkown |
| HY-P990766 | Sipavibart | Inhibitor | 98.00% | Unkown |
| HY-P990768 | Timcevibart | 98.313% | Unkown | |
| HY-P992456 | SAR-443809 | Inhibitor | / | Unkown |
| HY-145643 | Nepuvibart | Inhibitor | / | Unkown |
| HY-P990711 | Canrivitug | / | Unkown | |
| HY-P990725 | Nisfevitug | / | Unkown | |
| HY-P990814 | Anti-SARS-CoV-2 S protein Antibody (RBD epitope B, SARS2-34) | Inhibitor | / | Unkown |
| HY-P990815 | Anti-SARS-CoV-2 S protein Antibody (RBD epitope A, SARS2-01) | Inhibitor | / | Unkown |
| HY-P990816 | Anti-SARS-CoV-2 S protein Antibody (NTD, SARS2-29) | Inhibitor | / | Unkown |
| HY-P991082 | Anti-LAMP1/CD107a Antibody | Inhibitor | / | Unkown |
| HY-P991170 | Ibramvibart | Inhibitor | / | Unkown |
| HY-P992281 | Anti-Nucleocapsid Antibody (N-18) | / | Unkown | |
| HY-P992282 | Anti-Nucleocapsid Antibody (N-P10) | Inhibitor | / | Unkown |
| HY-P992283 | Anti-Nucleocapsid Antibody (N-P11) | Inhibitor | / | Unkown |
| HY-P992455 | SAR442085 | / | Unkown | |
| HY-P992457 | SAR444200 | Activator | / | Unkown |
| HY-P991491 | VIR-7229 | Inhibitor | / | Unkown |
| HY-P991763 | Anti-SARS-CoV-2 S protein (RBD) Antibody (SARS2-38) | Inhibitor | / | Unkown |